{"id":58423,"date":"2023-11-16T01:04:23","date_gmt":"2023-11-16T00:04:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/"},"modified":"2023-11-16T01:04:23","modified_gmt":"2023-11-16T00:04:23","slug":"ahf-echoes-wtos-call-for-patent-flexibilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/","title":{"rendered":"AHF Echoes WTO\u2019s Call for Patent Flexibilities"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–#COVID19<\/a>–AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling<\/a> on developing countries to put in place legal mechanisms to suspend intellectual property protections on medical commodities during public health emergencies.<\/p>\n

\n\u201cThese flexibilities already exist under the mandate of the WTO, but few countries take advantage of them, at least in part because they lack the statutory basis to invoke them. Having the necessary laws on the books would allow countries to quickly take advantage of this mechanism during outbreaks or pandemics \u2013 for this reason, we fully support Director-General Iweala\u2019s message,\u201d said AHF Director of Global Policy and Communications Denys Nazarov. \u201cTrying to figure out these things during a new or developing public health emergency is too late. As we saw with COVID-19, every day and week of delays results in preventable loss of life. It is in countries’ best interest to prepare now\u2014otherwise, they might find themselves once again shut out from access to technologies and medicines they need to keep their citizens alive.\u201d<\/p>\n

\nThe IP flexibilities are part of the WTO\u2019s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement. In practice, they have been invoked only a handful of times because countries that use them face significant political and economic pressure from wealthy countries and pharmaceutical companies not to suspend patents. With COVID-19, the WTO spent two years in a virtual deadlock over the suspension of patents on COVID-19 vaccines and related technologies, which ultimately did not result in any meaningful expansion of access to these lifesaving commodities.<\/p>\n

\nAbout AIDS Healthcare Foundation (AHF)<\/b><\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 45 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Europe. We are currently the largest non-profit provider of HIV\/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nUS MEDIA CONTACT:
\n
Ged Kenslea, <\/b>Senior Director, Communications, AHF
\n
+1 323 308 1833 work +1.323.791.5526 mobile
\n
gedk@aidshealth.org<\/a><\/p>\n

\nDenys Nazarov, <\/b>Director of Global Policy & Communications, AHF
\n
+1 323.308.1829
\n
denys.nazarov@aidshealth.org<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–#COVID19–AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling on developing countries to put in place legal mechanisms to suspend intellectual property protections on medical commodities during public health emergencies. \u201cThese flexibilities already exist under the mandate of the WTO, but few countries … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58423","6":"format-standard","7":"category-industry"},"yoast_head":"\nAHF Echoes WTO\u2019s Call for Patent Flexibilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AHF Echoes WTO\u2019s Call for Patent Flexibilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–#COVID19–AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling on developing countries to put in place legal mechanisms to suspend intellectual property protections on medical commodities during public health emergencies. \u201cThese flexibilities already exist under the mandate of the WTO, but few countries ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-16T00:04:23+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AHF Echoes WTO\u2019s Call for Patent Flexibilities\",\"datePublished\":\"2023-11-16T00:04:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/\",\"name\":\"AHF Echoes WTO\u2019s Call for Patent Flexibilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-11-16T00:04:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-echoes-wtos-call-for-patent-flexibilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AHF Echoes WTO\u2019s Call for Patent Flexibilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AHF Echoes WTO\u2019s Call for Patent Flexibilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/","og_locale":"en_US","og_type":"article","og_title":"AHF Echoes WTO\u2019s Call for Patent Flexibilities - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–#COVID19–AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling on developing countries to put in place legal mechanisms to suspend intellectual property protections on medical commodities during public health emergencies. \u201cThese flexibilities already exist under the mandate of the WTO, but few countries ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/","og_site_name":"Pharma Trend","article_published_time":"2023-11-16T00:04:23+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AHF Echoes WTO\u2019s Call for Patent Flexibilities","datePublished":"2023-11-16T00:04:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/"},"wordCount":387,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/","url":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/","name":"AHF Echoes WTO\u2019s Call for Patent Flexibilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-11-16T00:04:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ahf-echoes-wtos-call-for-patent-flexibilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AHF Echoes WTO\u2019s Call for Patent Flexibilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58423"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58423\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}